Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations
- Citation:
- J Clin Oncol vol 24 (suppl 16) 2001
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Eli Lily
- Grants:
- U10CA180821, U10CA180882, UG1CA189867 (NRG)
- Corr. Author:
- Authors:
- Priscilla Kaliopi Brastianos Katharine Dooley Susan Geyer Elizabeth R. Gerstner Timothy J. Kaufmann A. John Iafrate Mohammed Milhem Mary Roberta Welch Thomas J. Kaley Jan Drappatz Amy Chan Priya Kumthekar Carlos Kamiya Matsuoka Roy E. Strowd Adam L. Cohen Kurt Jaeckle Lindsay Robell Sandro Santagata Frederick G. Barker II Evanthia Galanis
- Networks:
- COLUMBIA, CRCWM, IA018, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-NH012, LAPS-NY016, LAPS-PA015, NC002, VA002
- Study
- Alliance-A071401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: